Inspiration On-Demand: How AI is Giving Tech-Savvy Study Teams an Edge
In this webcast, CEO Ed Ikeguchi shares his predictions for clinical trial technology in 2021 and beyond.
AI has the ability to power meaningful virtual clinical trials that allow sites to objectively measure changes in patient behavior and symptoms. While decentralized clinical trial technologies were particularly important during the pandemic, many of these remote practices will stick — the odds that the industry will return entirely to trial designs heavily reliant on in-person clinical visits seems low.
- Ed Ikeguchi MD, Chief Executive Officer at AiCure
- Lauren Sunshine, Director, Strategic Partnerships at AiCure (moderator)